Infections in infants fed formula supplemented with bovine milk fat globule membranes

Niklas Timby, Olle Hernell, Outi Vaarala, Merit Melin, Bo Lönnerdal, Magnus Domellöf

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Objectives: Observational studies have shown that even in high-income countries formula-fed infants have a higher incidence of acute otitis media (AOM), and gastrointestinal and respiratory tract infections during the first year of life compared with breast-fed infants. We hypothesized that components of the milk fat globule membrane (MFGM) may be responsible for some of these differences and that supplementation with bovine MFGM would decrease the infectious morbidity in formula-fed infants. Methods: In a double-blind randomized controlled trial, 160 formula-fed infants received experimental formula (EF) supplemented with bovine MFGM (EF) or unsupplemented standard formula (SF) from <2 months until 6 months of age. A breast-fed reference group consisted of 80 infants. Disease symptoms, health care contacts, and medication were recorded by the parents until 12 months of age. Serum immunoglobulin G for 10 pneumococcal serotypes was analyzed at 6 months of age. Results: The cumulative incidence of AOM during the intervention was lower in the EF group than in the SF group (1% vs 9%, P=0.034), and did not differ from the breast-fed reference group (0%, P=1.0). The incidence (25% vs 43%, P=0.021) and longitudinal prevalence (P=0.012) of antipyretic use were significantly lower in the EF group than in the SF group. Serum immunoglobulin G concentrations against pneumococcal serotypes 1, 5, and 14 were lower in the EF group than in the SF group. Conclusions: Supplementation of formula with bovine MFGM reduces the risk of AOM, decreases antipyretics use in formula-fed infants, and has immunomodulatory effects on humoral response against pneumococcus vaccine.

Original languageEnglish (US)
Pages (from-to)384-389
Number of pages6
JournalJournal of Pediatric Gastroenterology and Nutrition
Volume60
Issue number3
DOIs
StatePublished - Mar 7 2015

Fingerprint

Infant Formula
Otitis Media
Antipyretics
Breast
Membranes
Infection
Incidence
Immunoglobulin G
Streptococcus pneumoniae
Serum
Respiratory Tract Infections
Observational Studies
Gastrointestinal Tract
Vaccines
Randomized Controlled Trials
Parents
Morbidity
Delivery of Health Care
milk fat globule
Serogroup

Keywords

  • breast-feeding
  • infant formula
  • infections
  • milk fat globule membranes
  • otitis media

ASJC Scopus subject areas

  • Gastroenterology
  • Pediatrics, Perinatology, and Child Health

Cite this

Infections in infants fed formula supplemented with bovine milk fat globule membranes. / Timby, Niklas; Hernell, Olle; Vaarala, Outi; Melin, Merit; Lönnerdal, Bo; Domellöf, Magnus.

In: Journal of Pediatric Gastroenterology and Nutrition, Vol. 60, No. 3, 07.03.2015, p. 384-389.

Research output: Contribution to journalArticle

Timby, Niklas ; Hernell, Olle ; Vaarala, Outi ; Melin, Merit ; Lönnerdal, Bo ; Domellöf, Magnus. / Infections in infants fed formula supplemented with bovine milk fat globule membranes. In: Journal of Pediatric Gastroenterology and Nutrition. 2015 ; Vol. 60, No. 3. pp. 384-389.
@article{aaaaffb1b4ad4df284d641fedf21cfe3,
title = "Infections in infants fed formula supplemented with bovine milk fat globule membranes",
abstract = "Objectives: Observational studies have shown that even in high-income countries formula-fed infants have a higher incidence of acute otitis media (AOM), and gastrointestinal and respiratory tract infections during the first year of life compared with breast-fed infants. We hypothesized that components of the milk fat globule membrane (MFGM) may be responsible for some of these differences and that supplementation with bovine MFGM would decrease the infectious morbidity in formula-fed infants. Methods: In a double-blind randomized controlled trial, 160 formula-fed infants received experimental formula (EF) supplemented with bovine MFGM (EF) or unsupplemented standard formula (SF) from <2 months until 6 months of age. A breast-fed reference group consisted of 80 infants. Disease symptoms, health care contacts, and medication were recorded by the parents until 12 months of age. Serum immunoglobulin G for 10 pneumococcal serotypes was analyzed at 6 months of age. Results: The cumulative incidence of AOM during the intervention was lower in the EF group than in the SF group (1{\%} vs 9{\%}, P=0.034), and did not differ from the breast-fed reference group (0{\%}, P=1.0). The incidence (25{\%} vs 43{\%}, P=0.021) and longitudinal prevalence (P=0.012) of antipyretic use were significantly lower in the EF group than in the SF group. Serum immunoglobulin G concentrations against pneumococcal serotypes 1, 5, and 14 were lower in the EF group than in the SF group. Conclusions: Supplementation of formula with bovine MFGM reduces the risk of AOM, decreases antipyretics use in formula-fed infants, and has immunomodulatory effects on humoral response against pneumococcus vaccine.",
keywords = "breast-feeding, infant formula, infections, milk fat globule membranes, otitis media",
author = "Niklas Timby and Olle Hernell and Outi Vaarala and Merit Melin and Bo L{\"o}nnerdal and Magnus Domell{\"o}f",
year = "2015",
month = "3",
day = "7",
doi = "10.1097/MPG.0000000000000624",
language = "English (US)",
volume = "60",
pages = "384--389",
journal = "Journal of Pediatric Gastroenterology and Nutrition",
issn = "0277-2116",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Infections in infants fed formula supplemented with bovine milk fat globule membranes

AU - Timby, Niklas

AU - Hernell, Olle

AU - Vaarala, Outi

AU - Melin, Merit

AU - Lönnerdal, Bo

AU - Domellöf, Magnus

PY - 2015/3/7

Y1 - 2015/3/7

N2 - Objectives: Observational studies have shown that even in high-income countries formula-fed infants have a higher incidence of acute otitis media (AOM), and gastrointestinal and respiratory tract infections during the first year of life compared with breast-fed infants. We hypothesized that components of the milk fat globule membrane (MFGM) may be responsible for some of these differences and that supplementation with bovine MFGM would decrease the infectious morbidity in formula-fed infants. Methods: In a double-blind randomized controlled trial, 160 formula-fed infants received experimental formula (EF) supplemented with bovine MFGM (EF) or unsupplemented standard formula (SF) from <2 months until 6 months of age. A breast-fed reference group consisted of 80 infants. Disease symptoms, health care contacts, and medication were recorded by the parents until 12 months of age. Serum immunoglobulin G for 10 pneumococcal serotypes was analyzed at 6 months of age. Results: The cumulative incidence of AOM during the intervention was lower in the EF group than in the SF group (1% vs 9%, P=0.034), and did not differ from the breast-fed reference group (0%, P=1.0). The incidence (25% vs 43%, P=0.021) and longitudinal prevalence (P=0.012) of antipyretic use were significantly lower in the EF group than in the SF group. Serum immunoglobulin G concentrations against pneumococcal serotypes 1, 5, and 14 were lower in the EF group than in the SF group. Conclusions: Supplementation of formula with bovine MFGM reduces the risk of AOM, decreases antipyretics use in formula-fed infants, and has immunomodulatory effects on humoral response against pneumococcus vaccine.

AB - Objectives: Observational studies have shown that even in high-income countries formula-fed infants have a higher incidence of acute otitis media (AOM), and gastrointestinal and respiratory tract infections during the first year of life compared with breast-fed infants. We hypothesized that components of the milk fat globule membrane (MFGM) may be responsible for some of these differences and that supplementation with bovine MFGM would decrease the infectious morbidity in formula-fed infants. Methods: In a double-blind randomized controlled trial, 160 formula-fed infants received experimental formula (EF) supplemented with bovine MFGM (EF) or unsupplemented standard formula (SF) from <2 months until 6 months of age. A breast-fed reference group consisted of 80 infants. Disease symptoms, health care contacts, and medication were recorded by the parents until 12 months of age. Serum immunoglobulin G for 10 pneumococcal serotypes was analyzed at 6 months of age. Results: The cumulative incidence of AOM during the intervention was lower in the EF group than in the SF group (1% vs 9%, P=0.034), and did not differ from the breast-fed reference group (0%, P=1.0). The incidence (25% vs 43%, P=0.021) and longitudinal prevalence (P=0.012) of antipyretic use were significantly lower in the EF group than in the SF group. Serum immunoglobulin G concentrations against pneumococcal serotypes 1, 5, and 14 were lower in the EF group than in the SF group. Conclusions: Supplementation of formula with bovine MFGM reduces the risk of AOM, decreases antipyretics use in formula-fed infants, and has immunomodulatory effects on humoral response against pneumococcus vaccine.

KW - breast-feeding

KW - infant formula

KW - infections

KW - milk fat globule membranes

KW - otitis media

UR - http://www.scopus.com/inward/record.url?scp=84926358073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926358073&partnerID=8YFLogxK

U2 - 10.1097/MPG.0000000000000624

DO - 10.1097/MPG.0000000000000624

M3 - Article

VL - 60

SP - 384

EP - 389

JO - Journal of Pediatric Gastroenterology and Nutrition

JF - Journal of Pediatric Gastroenterology and Nutrition

SN - 0277-2116

IS - 3

ER -